Our Aim is to be at the forefront in curing the disease and reduce the suffering, discomfort of the patients. We have consistently focused on developing therapies for chronic disease, as we always trust prevention is better than cure.
We believe that our innovative products segments will play a key role in contributing towards a healthier community.
Our aim is to make the treatment simple, affordable, and efficient to treat Diabetes, focusing on Diabetes Mellitus.
Diabetes is also referred to as Black Death from the 14th Century. Epidemiology of Diabetes reveals 366 million people had Diabetes Mellitus in 2011; estimated that by 2030 this would have risen to 552 million people expected to have diabetes in 70% of developing countries.
Aetiology of diabetes also uncovers some of the lifestyle choices as a major factor for a cause of disease. Factors like lack of exercise, unhealthy meal planning, and overweight or obesity.
Zenon has a well-balanced portfolio, having capabilities of mitigating cardiovascular conditions as well as other diseases associated with it.
Of an estimated 58 million death globally from all causes in 2005, cardiovascular diseases accounted for 30%. As Cardiovascular disease places a significant economic burden on low or middle income countries, the resources available for its management in these countries are limited because of competing health priorities. Common causes which lead to cardiovascular disease are high blood pressure, diabetes, smoking, stress etc.
Over growing population, deforestation, industrialization, and increase in the number of vehicles are important factors for air pollution and leading to major respiratory diseases.
Respiratory disease causes an immense worldwide health burden. It is estimated that more than 200 million people are have chronic obstructive pulmonary disease and 65 million endure moderate to severe COPD. Each year, 4 million people die prematurely from chronic respiratory diseases.
Zenon’s Neurology segment comprises high standard medicines which are actively combating the fight against Neurological disorders and cure the suffering and discomfort of the patient.
Neurological disorders are increasingly recognized as one of the most prevalent disorders with high burden to the patients, their families, and society. Neurological disorders includes epilepsy, Alzheimer disease, dementia, migraine, headache etc. Factors like anxiety, psychological trauma, substance abuse, brain injury and other factors leads to mental illness.
Our portfolio is aiming to provide high quality products to alleviate the discomforts of the patients with gastrointestinal disorders.
Gastrointestinal (GI) and liver diseases are highly prevalent and lead to substantial health care utilization across the world. Many of these diseases also affect patients’ quality of life and productivity. Gastroenterology disorders comprises of Celiac disease, Crohn’s disease, constipation, diarrhoea, anal fissures, Haemorrhoids, Irritable bowel syndrome, Peptic ulcer disease etc.
Zenon’s specialist division of ophthalmics delivers multidisciplinary treatment for mild and chronic eye conditions.
Leading causes worldwide in 1990 and 2010 for blindness were cataract (39% and 33%, respectively), uncorrected refractive error (20% and 21%), and macular degeneration (5% and 7%), and for moderate and severe vision impairment were uncorrected refractive error (51% and 53%), cataract (26% and 18%), and macular degeneration (2% and 3%). Causes of blindness varied substantially by region. Worldwide and in all regions more women than men were blind or had moderate and severe vision impairment due to cataract and macular degeneration.